Texas Yale Capital Corp’s iShares US Pharmaceuticals ETF IHE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $831K | Sell |
12,675
-255
| -2% | -$16.7K | 0.03% | 277 |
|
|
2025
Q1 | $912K | Sell |
12,930
-500
| -4% | -$35.3K | 0.04% | 268 |
|
|
2024
Q4 | $883K | Hold |
13,430
| – | – | 0.04% | 264 |
|
|
2024
Q3 | $948K | Hold |
13,430
| – | – | 0.04% | 267 |
|
|
2024
Q2 | $891K | Hold |
13,430
| – | – | 0.04% | 269 |
|
|
2024
Q1 | $912K | Sell |
13,430
-1,000
| -7% | -$67.9K | 0.04% | 262 |
|
|
2023
Q4 | $892K | Hold |
14,430
| – | – | 0.04% | 261 |
|
|
2023
Q3 | $851K | Hold |
14,430
| – | – | 0.04% | 248 |
|
|
2023
Q2 | $862K | Hold |
14,430
| – | – | 0.04% | 260 |
|
|
2023
Q1 | $843K | Hold |
14,430
| – | – | 0.04% | 265 |
|
|
2022
Q4 | $895K | Hold |
14,430
| – | – | 0.05% | 252 |
|
|
2022
Q3 | $815K | Hold |
14,430
| – | – | 0.05% | 255 |
|
|
2022
Q2 | $922K | Hold |
14,430
| – | – | 0.06% | 240 |
|
|
2022
Q1 | $934K | Hold |
14,430
| – | – | 0.05% | 250 |
|
|
2021
Q4 | $960K | Hold |
14,430
| – | – | 0.05% | 250 |
|
|
2021
Q3 | $881K | Hold |
14,430
| – | – | 0.05% | 252 |
|
|
2021
Q2 | $893K | Hold |
14,430
| – | – | 0.05% | 252 |
|
|
2021
Q1 | $854K | Hold |
14,430
| – | – | 0.05% | 251 |
|
|
2020
Q4 | $863K | Hold |
14,430
| – | – | 0.06% | 250 |
|
|
2020
Q3 | $787K | Hold |
14,430
| – | – | 0.06% | 247 |
|
|
2020
Q2 | $740K | Hold |
14,430
| – | – | 0.06% | 253 |
|
|
2020
Q1 | $647K | Hold |
14,430
| – | – | 0.06% | 247 |
|
|
2019
Q4 | $770K | Hold |
14,430
| – | – | 0.05% | 283 |
|
|
2019
Q3 | $673K | Hold |
14,430
| – | – | 0.05% | 284 |
|
|
2019
Q2 | $725K | Sell |
14,430
-14,430
| -50% | -$725K | 0.05% | 281 |
|
|
2019
Q1 | $1.48M | Buy |
28,860
+14,430
| +100% | +$741K | 0.06% | 265 |
|
|
2018
Q4 | $677K | Hold |
14,430
| – | – | 0.06% | 256 |
|
|
2018
Q3 | $807K | Hold |
14,430
| – | – | 0.07% | 258 |
|
|
2018
Q2 | $728K | Hold |
14,430
| – | – | 0.06% | 259 |
|
|
2018
Q1 | $710K | Hold |
14,430
| – | – | 0.06% | 260 |
|
|
2017
Q4 | $743K | Buy |
14,430
+3,255
| +29% | +$168K | 0.06% | 263 |
|
|
2017
Q3 | $582K | Hold |
11,175
| – | – | 0.05% | 303 |
|
|
2017
Q2 | $578K | Hold |
11,175
| – | – | 0.05% | 299 |
|
|
2017
Q1 | $562K | Hold |
11,175
| – | – | 0.05% | 294 |
|
|
2016
Q4 | $527K | Hold |
11,175
| – | – | 0.05% | 289 |
|
|
2016
Q3 | $557K | Hold |
11,175
| – | – | 0.05% | 282 |
|
|
2016
Q2 | $538K | Hold |
11,175
| – | – | 0.05% | 289 |
|
|
2016
Q1 | $510K | Hold |
11,175
| – | – | 0.05% | 298 |
|
|
2015
Q4 | $602K | Hold |
11,175
| – | – | 0.06% | 257 |
|
|
2015
Q3 | $551K | Hold |
11,175
| – | – | 0.05% | 288 |
|
|
2015
Q2 | $651K | Hold |
11,175
| – | – | 0.05% | 276 |
|
|
2015
Q1 | $642K | Hold |
11,175
| – | – | 0.05% | 290 |
|
|
2014
Q4 | $564K | Hold |
11,175
| – | – | 0.05% | 299 |
|
|
2014
Q3 | $523K | Hold |
11,175
| – | – | 0.05% | 286 |
|
|
2014
Q2 | $503K | Hold |
11,175
| – | – | 0.06% | 254 |
|
|
2014
Q1 | $472K | Hold |
11,175
| – | – | 0.07% | 250 |
|
|
2013
Q4 | $440K | Hold |
11,175
| – | – | 0.07% | 201 |
|
|
2013
Q3 | $396K | Hold |
11,175
| – | – | 0.07% | 211 |
|
|
2013
Q2 | $371K | Buy |
+11,175
| New | +$371K | 0.06% | 205 |
|